Not all DNA damage is equal. Every time a cell divides, it has to copy its DNA, and some stretches of the genome are harder to copy than others. Cancer cells depend on a protective response to get ...

Personalized grafts, bioinks, and off-the-shelf tissues are advancing regenerative medicine toward broader clinical use.

Despite this advance, conventional CRISPR-Cas9 systems may introduce potentially harmful DNA breaks and cannot easily be ...

Lonza plans to more than double its U.S. footprint of CDMO sites by agreeing to acquire five such sites in the U.S. from Merck KGaA, Darmstadt, Germany, in a deal the companies would only say was ...

Study findings showed that the cancer cells organize themselves according to a consistent, predictable structural pattern across different patients.

Researchers say findings establish HOX genes as potential therapeutic targets for enhancing bone regeneration.

A new study finds that the VRC01 antibody initially protects against HIV infection, but resistant strains can cause breakthrough infections.

Differing apheresis practices at collection sites have a significant impact on samples and, therefore, the quality of cell ...

The findings show precise correction of the SCD mutation in the β-globin gene in three SCD patients as well as restored expression of adult hemoglobin (HbA).

In this GEN eBook readers will discover how epigenomic insights are improving every stage of the drug discovery pipeline, ...

Many of the blood proteins that could flag neurodegeneration are so scarce that standard assays barely register them. A new UK Biobank study will test whether an ultrasensitive platform can pick them ...

Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...